# Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease

> **NCT00005024** · PHASE3 · UNKNOWN · sponsor: **Jonsson Comprehensive Cancer Center**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** granisetron hydrochloride

## Key facts

- **NCT ID:** NCT00005024
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2014-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005024, "Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00005024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*